Cargando…
An mRNA vaccine elicits STING-dependent antitumor immune responses
Lipid-formulated RNA vaccines have been widely used for disease prevention and treatment, yet their mechanism of action and individual components contributing to such actions remain to be delineated. Here, we show that a therapeutic cancer vaccine composed of a protamine/mRNA core and a lipid shell...
Autores principales: | Chen, Zhe, Meng, Chaoyang, Mai, Junhua, Liu, Yongbin, Li, Hangwen, Shen, Haifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031366/ https://www.ncbi.nlm.nih.gov/pubmed/36970194 http://dx.doi.org/10.1016/j.apsb.2022.11.013 |
Ejemplares similares
-
Virus‐Mimic mRNA Vaccine for Cancer Treatment
por: Meng, Chaoyang, et al.
Publicado: (2021) -
Antitumor Immunity from Abdominal Flap-Embedded Therapeutic Cancer Vaccine
por: Liu, Xiaoling, et al.
Publicado: (2022) -
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
por: Ding, Liya, et al.
Publicado: (2018) -
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
por: Liu, Wei, et al.
Publicado: (2022) -
Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic Vaccine
por: Mai, Junhua, et al.
Publicado: (2021)